Identification of polycystic kidney disease gene, diagnostics and treatment
US5891628A · kind A · utility
20Cited by
1References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 2, 1995 |
| Grant date | Apr 6, 1999 |
| Priority date | — |
| Expiry date | Jun 2, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the identification of the autosomal dominant polycystic kidney disease (PKD) gene and high throughput assays to identify compounds that interfere with PKD activity. Interfering compounds that inhibit the expression, synthesis and/or bioactivity of the PKD gene product can be used therapeutically to treat polycystic kidney disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.